However, in some cases, off-label use is acceptable, especially in therapeutic areas with few treatment alternatives [42]
(PubMed) Kasaikina MV, Fomenko DE, Labunskyy VM, et al
Bahig H, Taussky D, Delouya G, Nadiri A, Gagnon-Jacques A, Bodson-Clermont P, Soulieres D
Diabetic Retinopathy and Glucagon-Like Peptide 1 Agonists Previous studies, including the DCCT, SUSTAIN-6, LEADER and TECOS trials, have linked exposure to incretin-based therapies and other hypoglycemic agents (i.e., insulin , injectable semaglutide, liraglutide , and oral sitagliptin ) to the exacerbation of pre-existing retinopathy (No authors listed, 1998, 1999
Being that it is zero calorie, non-stimulant, and a very clean, dope-free formula, it is created to improve workout performance and endurance